This study investigates the safety of an investigational medication used together with a combination of chemotherapy drugs, Gemcitabine and nab-Paclitaxel. The goal is to find the highest dose that can be safely given to participants. Chemotherapy uses strong drugs to kill cancer cells, and this study aims to see how well they work with the investigational medication.
Participants in the study will receive the investigational medication along with the chemotherapy drugs. Researchers will monitor the participants closely to see how their bodies react to the combination and to determine the safest dose that can be administered.
- Who can participate: Participants must be adults diagnosed with cancer, eligible for chemotherapy treatment, and meet specific health criteria.
- Study details: Participants will take the investigational medication along with chemotherapy drugs. They will be monitored for safety and reactions to the treatment.
